The GLORIOUS trial found that an intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) during heart surgeries ...

Credit: Getty Images Experts weigh in on the ramifications of GLP ... 1 medications and to optimize the delivery with multi-use pens and oral formulations. 13,14 “There is also a need to assess the ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Despite their benefits, access to GLP-1 medications remains inequitable. Perceived high costs, inconsistent insurance coverage, and drug shortages have created barriers, limiting who is currently ...

An Arkansas Legislative Council subcommittee has recommended that the state's health insurance plans for public school and ...

Though there are multiple possible reasons that people may discontinue treatment with GLP-1 receptor agonists, high out-of-pocket costs and side effects appear to be among the leading culprits. But a ...

Related Wegovy, other weight-loss drugs might help with alcoholism, opioid addiction Weight-loss drugs can help stroke survivors prevent recurrence Weight-loss surgeries decline 25% as GLP-1 drugs ...

In the univariate analysis, those on an SGLT-2i/GLP-1 RA had a reduced risk for mortality, incident MI, and composite. (HealthDay News) — For patients with ischemic stroke, sodium-glucose ...

GLP-1 weight-loss drugs are having a “mild impact ... ourselves competitively for today and into the future.” More cost pressure on cocoa looms One of Hershey’s challenges going forward ...

PHILADELPHIA — New research provides more evidence that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) do not increase the risk for pancreatic cancer. Instead, the large electronic health ...

Subhani's team focused at results from six studies conducted before August of this year, including two "gold standard" clinical trials comprising a total of more than 88,000 people, about 44% of who ...